News

Filter

Current filters:

PromactaAmgen

FDA 2008 NCE appros exceed expectations

12-01-2009

Having made a slow start to 2008, and giving a number of excuses for its slowness of action, the US...

AmgenDaiichi SankyoeltrombopagGlaxoSmithKlineGSKLillyNplatePromactaRomiplostimSankyoSchering PloughSchering-Plough

Stock Commentary - New York week to Oct 27, 2008

03-11-2008

NEW YORK: equities had yet another volatile week in the reporting period to October 27, with the Dow…

AmgenAmylinAranespBristol-Myers SquibbByettaDarbepoetin AlfaeltrombopagEpoetin AlfaEpogenExenatide InjectionGlaxoSmithKlineGSKProcritPromacta

Back to top